Citryll doses first subject in Phase IIa trial of monoclonal antibody for RA
Netherlands-based biotech Citryll has dosed the first subject in the randomised Phase IIa trial, Citydream, assessing its monoclonal antibody CIT-013,…
Orthopedic Devices
-
-
Amber Implants reports positive initial results for spinal device
Netherlands-based Amber Implants has completed enrolment in its first-in-human trial evaluating the VCFix spinal system for the treatment of vertebral…
-
ZKR Orthopedics secures IDE approval for LIFT implant US trial
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to ZKR Orthopedics to begin a pivotal…
-
Amber Implants commences first-in-human trial for vertebral fracture device
Amber Implants has kickstarted a clinical trial investigating the safety and effectiveness of its implant designed to treat vertebral compression…
-
FDA approves IDE for HYDRAFIL system in degenerative disc disease study
The US Food and Drug Administration (FDA) has granted ReGelTec an investigational device exemption (IDE) for the company’s HYDRAFIL system.…
-
MediProbe Research and Emblation initiate toenail fungus treatment trial
Scottish medtech company Emblation has kicked off its trial in Canada investigating the use of its Swift microwave skin therapy…
-
IDE clinical trial for artificial cervical disc completes enrollment
Synergy Spine Solutions has enrolled the last patient in its investigational device exemption (IDE) clinical trial. The 1-Level Synergy Disc…
